Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.20.1
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statements of Operations    
Product revenue $ 0 $ 0
Cost of product revenue 0 0
Gross profit 0 0
Operating expenses:    
Research and development 350,664 218,216
General and administrative 579,770 468,390
Total operating expenses 930,434 686,606
Loss from continuing operations before interest (930,434) (686,606)
Interest expense, net 67 7,118
Loss from continuing operations (930,501) (693,724)
Loss from discontinued operations 0 (347,175)
Net loss $ (930,501) $ (1,040,899)
Loss from continuing operations per share - basic and fully diluted (in dollars per share) $ (0.31) $ (0.49)
Loss from discontinued operations per share - basic and fully diluted (in dollars per share) 0.00 (0.24)
Net loss per share - basic and fully diluted $ (0.31) $ (0.73)
Weighted average number of shares outstanding - basic and fully diluted (in dollars) 2,968,394 1,433,069